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Abstract
The tumor suppressors Retinoblastoma (Rb) and p53 are frequently inactivated in liver dis-
eases, such as hepatocellular carcinomas (HCC) or infections with Hepatitis B or C viruses.
Here, we discovered a novel role for Rb and p53 in xenobiotic metabolism, which represent
a key function of the liver for metabolizing therapeutic drugs or toxins. We demonstrate that
Rb and p53 cooperate to metabolize the xenobiotic 3,5-diethoxycarbonyl-1,4-dihydrocolli-
dine (DDC). DDC is metabolized mainly by cytochrome P450 (Cyp)3a enzymes resulting in
inhibition of heme synthesis and accumulation of protoporphyrin, an intermediate of heme
pathway. Protoporphyrin accumulation causes bile injury and ductular reaction. We show
that loss of Rb and p53 resulted in reduced Cyp3a expression decreased accumulation of
protoporphyrin and consequently less ductular reaction in livers of mice fed with DDC for 3
weeks. These findings provide strong evidence that synergistic functions of Rb and p53 are
essential for metabolism of DDC. Because Rb and p53 functions are frequently disabled in
liver diseases, our results suggest that liver patients might have altered ability to remove
toxins or properly metabolize therapeutic drugs. Strikingly the reduced biliary injury towards
the oxidative stress inducer DCC was accompanied by enhanced hepatocellular injury and
formation of HCCs in Rb and p53 deficient livers. The increase in hepatocellular injury might
be related to reduce protoporphyrin accumulation, because protoporphrin is well known for
its anti-oxidative activity. Furthermore our results indicate that Rb and p53 not only function
as tumor suppressors in response to carcinogenic injury, but also in response to non-carci-
nogenic injury such as DDC.
Introduction
Xenobiotics are compounds originating from outside the body, such as drugs and toxins. Once
entered into the mammalian body, xenobiotics get removed by xenobiotic metabolism, which
occurs predominately in the liver and to some extend in the intestine. Cytochrome P450
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enzymes (Cyps) are the key components for oxidation and associated detoxification of xenobi-
otics [1]. The goal is to detoxify these foreign chemical species and convert them into molecules
that are soluble and readily excreted. The large substrate-binding cavities of Cyps allow them
to accommodate a wide range of substrates, most of which are hydrophobic [2]. In some cases
the Cyp activity can be altered by interaction with the xenobiotics. Since modification in Cyps
activity will influence the metabolism and detoxification of xenobiotics, identifying factors that
change Cyps expression will be important for mammals exposed to toxins and for patients
receiving drugs that cause severe side effects or have a small therapeutic window [3].
Recent studies provide some evidence that expression of Cyps can be regulate by the tumor
suppressor genes Retinoblastoma (Rb) and p53 [3,4], however the consequences for metabo-
lism of xenobiotics in livers are unknown. Both Rb and p53 are frequently inactivated in the
liver, because of infection with Hepatitis B or C viruses. Both type of viruses produces viral pro-
teins that can bind to these tumor suppressors and thereby inhibit its functions [5–8]. Further-
more genetic analysis of HCC revealed that a subset of liver tumor carry Rb and p53 mutations
[5]. Rb and p53 play crucial roles as cell cycle regulators [9]. Apart for their role in cell-cycle
control, Rb and p53 have been implicated in many cellular processes including DNA-damage
responses, DNA repair, DNA replication, cellular differentiation and apoptosis [10].
The Rb protein and its family members, p107 and p130, mediate cellular response through
the control of E2F transcription factor activity and the expression of their target genes during
cell cycle progression. Under resting condition or G0 phase, hypophosphorylated pRB binds
and inhibits E2F transactivation domain. In proliferative stage, pRB is inactivated by Cyclin-
CDK (cyclin-dependent kinase) complexes and becomes hyperphophorylated. This inactive
pRB then releases E2F to allow the induction of genes involve in the transition from G1 phase
to S phase of cell cycle. Therefore, the loss or mutation of Rb leads to deregulation of E2F and
inappropriate proliferation which can contribute to cancer development [10,11]. One pathway
likely to mediate cell cycle control in the absence of Rb is the p53 pathway [4]. In response to
cellular stress, the transcription factor p53 is phosphorylated and binds to specific target genes
involved in DNA repair, cell cycle progression, and apoptosis [9,12]. Multiple mechanism have
been discovered that resulted in inactivation of the p53 pathway in HCC [13,14].
Although combined loss of Rb and p53 is a frequent event in human cancer, and many dif-
ferent cancer patients are treated with xenobiotic anti-cancer drugs, the impact of Rb and p53
loss on xenobiotic metabolism is unknown. To determine the role of Rb and p53 in xenobiotic
metabolism, we exposed mice with liver-specific ablation of Rb and p53 to the xenobiotic
3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC). Exposure of DDC to mice is an established
xenobiotic-induced mouse model of porphyrias, a disease where excess amounts of protopor-
phyrin accumulate in the body. Protoporphyrin is required for synthesis of heme, which carries
the oxygen in the blood. DDC interacts directly with Cyps, in particular Cyp3a [15], leading to
the generation of an inhibitor of ferrochelatase, a key enzyme required for heme biosynthesis
pathway. Inhibition of ferrochelatase causes accumulation of its substrate protoporphyrin
especially in bile ducts triggering cholangitis and ductular reactions [15].
Here, we used the DDC mouse model, and demonstrate that combined deletion of Rb and
p53 in the liver reduces Cyp3a expression and DDC metabolism, which led to less accumula-
tion of DDC-metabolite protoporphyrin and less bile duct injury. Moreover, we discovered
that hepatocellular injury was instead increased and HCC developed in Rb and p53 deficient
livers in response to DDC. These findings show that Rb and p53 function are required for effi-
cient metabolism of the xenobiotic DDC and tumor suppression in the liver.
Rb and p53 for Xenobiotic Metabolism
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Materials and Methods
Animals
The albumin (alb) enhancer promoter and cre recombinase/loxP system were used to generate
conditional liver specific Rb and/or p53 knockout mice. The alb gene promoter provides spe-
cific deletion of the gene of interest in the liver, as alb is expressed mainly in hepatocytes and
bile duct cells [16]. Cre recombinase facilitates the excision of target gene which flanked by two
loxP sites [17]. In this study, mice expressing Cre recombinase under the control of albumin
[18] were crossed with mice harboring Rb (Rbf/f) and/or p53 (p53f/f) flanked by two loxP sites
[19]. All mice were bred at least in 7th generations FVB. Genotyping was performed by poly-
merase chain reaction on DNA isolated from ear cuts.
Treatment
8–9 weeks old, male and female mice were fed ad libitum with diet contained 0.1% DDC (Bio-
serv, New Jersey, USA) for 3 weeks, and then the mice were harvested (5 mice per group) or
changed to normal diet for life span analysis (5–11 mice per group). Control littermate mice
were fed a standard mouse diet. No differences were observed between male and female in the
responses to DDC. All mice were housed under standard laboratory conditions. During DDC
feeding and survival study, health status and body weight of the mice were monitored 2–3
times a week. All mice survived 3 weeks DDC feeding. The mice were euthanized using CO2
inhalation. For the life span studies mice were euthanized when they fulfilled one of the follow-
ing human end point criteria: (1) more than 10% change in body weight within one week (2)
abnormal behaviors (not response to stimulus, continuous tremble, self-mutilation) (3) piloer-
ection longer than 24 hours (4) abnormal enlargement of abdomen (5) labored respiration (6)
loss of ability to ambulate. Experiments were performed in accordance with institutional and
national guidelines approved by Utrecht University Animal Ethics Committee.
Protoporphyrin Measurement
Unstained liver sections were photographed under polarization light to quantify the accumula-
tion of fluorescent protoporphyrin. Adobe photoshop was used to switch the fluorescent proto-
porphyrin to black color, ImageJ software was then applied to quantify protoporphyrin area.
At least 20 randomized liver regions per mouse were analyzed.
Serum Biochemistry
Blood samples were collected from inferior vena cava before removing the liver. Blood samples
were centrifuged to collect serum. Serum alanine aminotransferase (ALT) and serum aspartate
aminotransferase (AST) were measured using the UniCel DxC Synchrome (Beckman Coulter,
Woerden, NL).
Statistical Analysis
All experimental data are shown as mean ± standard error of mean (SEM). The statistics analy-
ses for bar graphs were performed with SPSS. P-values were set at P< 0.05 and calculated
using Kruskal Wallis and Mann-Whitney U test. Survival curve was drawn and statistical dif-
ference was calculated using SPSS log rank test.
Additional information on methods is provided in S1 File: Materials and Methods.
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Results
Combined loss of Rb and p53 suppresses protoporphyrin accumulation
and ductular reaction in livers of mice fed with DDC
Previous studies have demonstrated that expression of genes involved in xenobiotic metabo-
lism are reduced in Rb and Rb/p53 deficient cells [3,4]. To determine in vivo whether Rb and
p53 functions are required for metabolism of xenobiotics, we fed mice a diet containing the
xenobiotic DDC. Since DDC is metabolized in the liver, we generated mice that are deficient
for Rb and p53 in the liver. To this end, conditional Rbf/f and p53f/f mice were crossed with
transgenic mice expressing the cre-recombinase under the liver-specific albumin enhancer pro-
moter to obtain the deletion of Rb and p53 function in mouse livers. The endogenous albumin
gene is expressed during embryonic development in liver progenitor cells which then give rise
to hepatocytes and bile duct cells [20,21], leading to efficient deletion of Rb and p53 in those
three parenchymal liver cell types of adult mice. Genotyping PCR of liver sections confirmed
the deletion of Rb and p53 (S1 Fig).
Adult wild-type mice (Wt: Alb-/-; Rbf/f;p53f/f), mice with liver-specific deletion of RbΔ/Δ
(Alb+/-; RbΔ/Δ), mice with liver-specific deletion of p53Δ/Δ (Alb+/-; p53Δ/Δ), and mice with liver-
specific combined deletion of RbΔ/Δ;p53Δ/Δ (Alb+/-; RbΔ/Δ; p53Δ/Δ) were fed a diet containing
0.1% DDC for 3 weeks. All the mice fed with DDC developed yellowish mucous membrane
and the color of livers was clearly darker compared to untreated groups (S2A Fig). Histological
analysis of hematoxylin and eosin stained liver sections of DDC-treated mice revealed thatWt,
RbΔ/Δ and p53Δ/Δ livers displayed strong accumulation of intraductal dark-brown protoporphy-
rin pigment plugs accompanied with ductular reactions near portal regions (Fig 1A). In con-
trast, protoporphyrin accumulation and ductular reaction were markedly reduced in RbΔ/Δ;
p53Δ/Δ livers. Quantitative analysis of protoporphyrin accumulation by examining unstained
liver slides under polarizing light confirmed the reduced accumulation of protoporphyrin in
RbΔ/Δ;p53Δ/Δ livers (Fig 1B). The protoporphyrin accumulation within the bile ducts provokes
a ductular reaction leading to the formation of smaller bile ducts through proliferation of liver
progenitor cells (oval cells). In addition, this ductular reaction is accompanied with a ccumula-
tion of hepatic stellate cells, biliary fibroblasts, and inflammatory cells such as macrophages
and neutrophils. We have performed immunohistochemical analysis with markers for oval/bile
duct cells (CK19), hepatic stellate cells (GFAP), and macrophages (F4/80), and verified that the
number of oval cells, macrophages and hepatic stellate cells were markedly reduced in RbΔ/Δ;
p53Δ/Δ livers compared to other genotypes (Fig 1A; S3A and S3B Fig). These findings were also
supported by quantitative PCR analysis for CK19 (Fig 1C). The baseline CK19mRNA levels
were not different betweenWt and RbΔ/Δ;p53Δ/Δ untreated mice. After DDC treatment, CK19
mRNA levels increased 6-8-fold inWt, RbΔ/Δ and p53Δ/Δ livers, whereas RbΔ/Δ;p53Δ/Δ livers
showed only a 2-fold increase in CK19 expression. Together these findings demonstrate that
loss of Rb and p53 in the liver suppresses protoporphyrin accumulation and ductular reaction
in mice fed with DDC.
Cyp3a expression is reduced in RbΔ/Δ;p53Δ/Δ livers after DDC feeding
To explore why loss of Rb and p53 mitigates DDC-induced protoporphyrin accumulation in
the liver, we first evaluated whether Cyp3a expression, the enzyme that mainly metabolizes
DDC, was altered. We performed qPCR analysis, and discovered that Cyp3a11mRNA levels
were induced inWt livers upon DDC exposure (Fig 1D). Importantly, RbΔ/Δ;p53Δ/Δ livers show
marked reduction in Cyp3a expression compared toWt livers. Inactivation of Rb or p53 alone
reduced Cyp3a expression as well, but to a lesser extent than the combinatorial knockout.
Rb and p53 for Xenobiotic Metabolism
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Fig 1. Combined loss of Rb and p53 suppresses protoporphyrin accumulation, ductular reaction and Cyp3a expression in livers of DDC-fedmice.
(A) Representative pictures of H&E and CK19 staining on liver sections frommice of indicated genotypes after 3 weeks of DDC feeding. Arrows indicate
protoporphyrin accumulation. (B) Semi-quantitative analysis of percentage area of protoporphyrin accumulation frommice fed with normal chow or 3-weeks
Rb and p53 for Xenobiotic Metabolism
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These findings suggest that loss of Rb and p53 reduces Cyp3a expression and thereby inhibiting
DDC metabolism and protoporphyrin accumulation. Next, we investigated whether the
expression levels of ferrochelatase, the enzyme that converts protoporphyrin into heme [22],
were changed in RbΔ/Δ;p53Δ/Δ livers. However, mRNA levels of ferrochelatase (FECH) did not
differ between genotypes (Fig 1E), indicating that the observed phenotypes were most likely
not related to alterations in ferrochelatase expression.
Loss of Rb and p53 results in increased hepatocellular injury after DDC
exposure
Serological evaluation of the alanine aminotransferase (ALT), an established marker for liver
injury, revealed that ALT levels were strongly increased in mice fed with DDC (Fig 2A).
Despite that RbΔ/Δ;p53Δ/Δ livers displayed less protoporphyrin accumulation and ductular reac-
tion, their serum ALT levels were higher compared to other genotypes. To investigate whether
increased hepatic injury was associated with enhanced cell death in RbΔ/Δ;p53Δ/Δ livers, we
employed a terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick
end labeling (TUNEL) on liver sections (Fig 2B). Quantification of TUNEL positive liver cells
revealed that all mice treated with DDC showed an increase in the number of dead hepatocytes
compared to untreated mice. Hardly any TUNEL positive bile duct epithelial cells or oval cells
were detected. Combined Rb and p53 loss in the liver resulted in a significant increase in hepa-
tocellular death in mice fed DDC compared to other genotypes (Fig 2B and 2C). These findings
indicate that Rb and p53 deficient livers experience less ductular reaction, but instead more
hepatocellular injury under DDC exposure.
Inactivation of Rb and p53 accelerates hepatocellular proliferation and
polyploidization in response to DDC
Since RbΔ/Δ;p53Δ/Δ liver/body weight ratios were higher compared toWt livers in mice that
received a DDC diet for 3 weeks (S2B Fig), we investigated whether increased hepatocellular
death in RbΔ/Δ;p53Δ/Δ livers was compensated by accelerating cell division and/or polyploidiza-
tion of hepatocytes. To this end, we performed immunohistochemical analysis on liver sections
with antibodies directed Ki67 (stained cells in cell cycle phase G1, S, G2/M) and phospho-his-
tone 3 (PH3, stained cells in G2/M). In mice fed a normal chow, inactivation of Rb and p53 did
not alter the proliferation rate of liver cells. In contrast, when mice were fed a DDC diet, RbΔ/Δ;
p53Δ/Δ livers displayed a marked increase in mitotic figures, Ki67 and PH3 positive hepatocytes
compared toWt, RbΔ/Δ or p53Δ/Δ livers (Fig 2B, 2D and 2E). Proliferation rates of bile duct cells
and oval cells did not differ between the four different genotypes (S4A and S4B Fig). Further-
more, we observed that several RbΔ/Δ;p53Δ/Δ hepatocytes were multinucleated or contained
extreme large nuclei, suggesting that these hepatocytes underwent enhanced polyploidization
(Fig 2F). Two board certified veterinary pathologist have analyzed and scored these lesions.
The anisokaryosis score, a measurement for differences in nuclear size, and the incidence of
multinucleation were the highest in RbΔ/Δ;p53Δ/Δ livers (Fig 2F and 2G). Rb or p53 ablation
alone already resulted in higher anisokaryosis and multinucleation, but to lesser degree than
RbΔ/Δ;p53Δ/Δ livers. These findings suggest that the enhanced hepatocellular death in Rb and
p53 deficient hepatocytes is compensated by increased proliferation and polyploidization of
surrounding hepatocytes.
DDC diet (n = 5 per group). (C) (D) (E) Expression of CK19, Cyp3a11 and FECHwas measured by qPCR in livers of indicated genotypes. -DDC, Rbf/ f; p53f/f,
were normalized to 1. Data presented as average ± SEM. * P < 0.05 compared to +DDC, Rbf/ f; p53f/f, # P < 0.05 compared to +DDC, RbΔ/Δ.
doi:10.1371/journal.pone.0150064.g001
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Fig 2. Loss of Rb and p53 results in increased hepatocellular injury, hepatocyte proliferation and polyploidization after DDC. (A) ALT and AST
serum levels (B) Representative pictures of TUNEL, Ki67 and PH3 staining on liver sections (C) Percentage of TUNEL positive hepatocyte nuclei (D)
Percentage of PH3 positive hepatocyte nuclei (E) Mitotic index of hepatocytes (F) Multinucleated hepatocytes (G) Anisokaryosis score of hepatocytes from
Rb and p53 for Xenobiotic Metabolism
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Inactivation of Rb and p53 shortens life span and accelerates HCC
formation after DDC exposure
To determine whether increased hepatocellular death and proliferation in RbΔ/Δ;p53Δ/Δ livers
after 3 weeks of DDC exposure had any long-term effects on liver homeostasis, mice were sub-
sequently aged on a normal diet. Alb+/-; RbΔ/Δ; p53Δ/Δmice needed to be sacrificed already after
approximately 7.5 months after DDC feeding, because of severe swelling of the abdominal cav-
ity. Alb+/-;p53Δ/Δmice lived longer, but needed to be sacrificed after approximately 15.5
months, whereas Alb+/-; RbΔ/Δmice were euthanized at approximately 20 months after DDC
exposure (Fig 3A; Table 1). Non-DDC treated Alb+/-; RbΔ/Δ; p53Δ/Δmice had longer life span
(mean survival time 527 days) (data not shown) compared to DDC treated Alb+/-; RbΔ/Δ;
p53Δ/Δmice (mean survival time 300 days). Necropsy of mice with swollen abdomen revealed
the presence of visible liver neoplasm. Tumor incidences differ among groups, which were
27.3%, 40% and 90% in RbΔ/Δ, p53Δ/Δ and RbΔ/Δ;p53Δ/Δ livers, respectively (Fig 3A; Table 1). No
liver tumors were observed in the age-matched control mice lacking Alb-Cre. Histologic exami-
nation of the liver samples was performed in a blinded fashion by a board certified veterinary
pathologist. While livers harboring a single tumor suppressor loss were predominantly classi-
fied as well-differentiated HCC, livers deficient for both Rb and p53 were categorized as undif-
ferentiated carcinoma (Fig 3B; Table 1). The results indicated that Rb and p53 have important
tumor suppressor functions in hepatocytes after DDC-induced liver injury.
Discussion
Metabolism of xenobiotics occurs in mammals predominantly in the liver. Human patients
with liver disease or liver cancer are treated frequently with xenobiotic drugs, and the efficacy
of drug treatment depends on Cyp enzymes since they are required for xenobiotic metabolism.
Our studies demonstrate that Rb and p53, two proteins often inactivated in liver diseases, are
essential for Cyp expression. These findings are in line with studies demonstrating that loss of
Rb and p53 results in reduced expression of a number of genes involved xenobiotic metabo-
lism, such as Cyp3a11 and Cyp3a25 [3,4]. However, we show now that reduced expression of
Cyp through liver-specific inactivation of Rb and p53 is accompanied by reduced metabolism
of the xenobiotic DDC through evaluation of protoporphyrin, an in vivomeasurable fluores-
cent product that accumulates in response to xenobiotic metabolism of DDC.
DDC interacts with Cyps in particular Cyp3as, proteins that contain a heme group [23].
During oxidative metabolism the 4-methyl group of DDC is transferred to one of pyrrole nitro-
gen of the heme group of Cyps leading to the formation of N-methyl protoporphyrin IX [22]
(Fig 4). This N-methyl protoporphyrin IX then migrate from the site of production the endo-
plasmatic reticulum of hepatocytes to the inner membrane of the mitochondria to inhibit fer-
rochelatase, a key enzyme in the heme biosynthesis pathway. The mechanism by which N-
methyl protoporphyrin IX inhibit ferrochelatase is thought to occur through competitive sub-
strate inhibition with the endogenous protoporphyrin [22]. The block at this level of the heme
biosynthesis causes marked accumulation of protoporphyrin in bile ducts [22,23] (Fig 4).
Human patients with porphyria display a similar phenotype because they carry mutations in
ferrochelatase gene [24,25]. Because DDC interacts directly with Cyp enzymes to generate the
ferrochelatase inhibitor, reduced expression of Cyp enzymes in RbΔ/Δ;p53Δ/Δ livers would likely
results in less production of the ferrochelatase inhibitor and thereby prevent the accumulation
mice of indicated genotypes fed with normal chow or 3-weeks DDC diet. Data presented as average ± SEM. * P < 0.05 compared to +DDC, Rbf/ f; p53f/f, #
P < 0.05 compared to +DDC, RbΔ/Δ, $ P < 0.05 compared to +DDC, p53Δ/Δ.
doi:10.1371/journal.pone.0150064.g002
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of its substrate protoporphyrin (Fig 4). Alternatively, loss of Rb and p53 could directly regulate
the expression levels of ferrochetalase, but qPCR analysis revealed no changes in expression
(Fig 1E), ruling out any direct regulation mechanism on ferrochelatase expression.
Increase protoporphyrin crystals induce injury to biliary epithelial cells. The injured biliary
epithelial cells then secrete proinflammatory and chemotactic cytokines, such as TNF-α and
IL-6, causing acute cholangitis, ductular reaction and finally biliary fibrosis [26]. Increase bili-
ary pressure as a result of partial bile duct obstruction due to protoporphyrin plugs may be
another mechanism that triggers ductular reaction in DDC model [15]. Since inactivation of
Rb and p53 reduced the accumulation of protoporphyrin, consequently less biliary injury was
Fig 3. Inactivation of Rb and p53 shortens life span and accelerates hepatocellular carcinoma formation after DDC exposure. (A) Survival and time
to tumor curves of mice of indicated genotypes after feeding with DDC diet for 3 weeks at young ages and aged with normal chow. (B) Representative
macroscopic pictures of H&E staining of liver tumors of mice feeding with DDC diet for 3 weeks at young ages and aged with normal chow. White and black
dotted lines indicate the borders between normal liver tissue (L) and tumor (T).
doi:10.1371/journal.pone.0150064.g003
Rb and p53 for Xenobiotic Metabolism
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observed and the degree of cholangitis and ductular reaction was dramatically decreased (Fig
4). Alternatively, Rb and p53 function might be required for the ductular reaction, especially
for the proliferation of the liver progenitor cells. We have isolated and cultured liver progenitor
cells utilizing the liver organoid technology [27], but we observed no differences in cell prolifer-
ation between Wt and Rb/p53 deficient liver progenitor cells (data not shown). These findings
suggest that the reduced ductular reaction is not due to the fact that Rb and p53 are essential
for liver progenitor cell proliferation, but rather due to reduced accumulation of protoporphy-
rin, the trigger for the biliary injury. Besides the reduced liver progenitor cells accumulation,
we have observed reduced infiltration of inflammatory cells, which might be related to reduce
Table 1. Percentage tumor incidence, mean time to tumors and tumor classifications of mice with the indicated genotypes.
Genotype % tumor incidence Mean time to tumors (days) % Well-differentiated HCC % undifferentiated carcinoma
AlbCre-/-; Rbf/f; p53f/f 0% (0/5) n.a. n.a. n.a.
AlbCre+/-; RbΔ/Δ 27.3% (3/11) 600 100% (3/3) 0%
AlbCre+/-; p53Δ/Δ 40% (2/5) 464* 50% (1/2) 50% (1/2)
AlbCre+/-; RbΔ/Δ; p53Δ/Δ 90% (9/10) 227* 22.2 (2/9) 77.8% (7/9)
AlbCre+/-; p53Δ/Δ mice have a signiﬁcant lower mean time to tumor compared to AlbCre+/-; RbΔ/Δ mice (*P<0.05); AlbCre+/-; RbΔ/Δ; p53Δ/Δ has a
signiﬁcant lower mean time to tumor compared to AlbCre+/-; p53Δ/Δ (*P< 0.05; SPSS log rank test). n.a., not applicable.
doi:10.1371/journal.pone.0150064.t001
Fig 4. Scheme for the role of RB and p53 in DDCmetabolism. DDC interacts with Cyp in particular Cyp3a to form N-methyl protoporphyrin IX which
inhibits ferrochelatase causing an accumulation of protoporphyrin in the bile ducts. Bile duct injury induces ductular reaction and inflammation. In addition,
DDC induces reactive oxygen species (ROS) and oxidative stress causing hepatocellular injury. Protoporphyrin, on the other hand, acts as an antioxidant
and protects hepatocytes. Rb and p53 are important for Cyp expression. Oxidative stress activates Rb and p53. Loss of Rb and p53 results in reduced
expression of Cyp3a, therefore less production of the ferrochelatase inhibitor and thereby prevents the accumulation of its substrate protophorphyrin.
Consequently, less bile injury and ductular reaction was observed. The reduction of protoporphyrin, an antioxidant, increases oxidative induced
hepatocellular injury and later liver tumors develop.
doi:10.1371/journal.pone.0150064.g004
Rb and p53 for Xenobiotic Metabolism
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biliary injury. However we cannot exclude that deletion of Rb and p53 in hepatocytes also
resulted in a compromised immune response, because previous studies described that Rb
potentiates the innate immune response in hepatocytes [28].
Although RbΔ/Δ;p53Δ/Δ livers displayed less biliary injury, hepatocellular injury was more
severe, since ALT levels and the number of dead hepatocytes were increased. Loss of hepato-
cytes was partially compensated by increased cell division of surrounding hepatocytes as quan-
tified by counting mitotic figures and immunohistochemical staining for the proliferation
marker Ki67 and PH3. In addition, multiple Rb and p53 deficient hepatocytes were bigger in
size and contained multiple nuclei or enlarged single nuclei, indicating that these cells are poly-
ploid and that loss of hepatocytes was also partially compensated by increasing the size of sur-
rounding hepatocytes.
Polyploidy, the addition of one multiple complete sets of chromosomes, starts in rodents
after weaning and the degree of polyploidy increases with age [29]. However, pathological poly-
ploidization can also be induced by DNA damage and oxidative stress [30,31]. Previous work
demonstrated that deletion of Rb in the liver is associated with increased DNA damage and
enhanced polyploidy in hepatocytes [32,33], which is consistent with our observation that liver
specific deletion of Rb increases polyploidy. Inactivation of p53 also results in enhanced hepa-
tocyte polyploidy, especially in response to partial hepatectomy [34]. Interestingly, in our study
we found in the livers of DDC-fed mice that p53 deletion resulted in the formation of hepato-
cytes with enlarged nuclei, and in addition we observed the formation of large multiple multi-
nucleated cells with more than 2 nuclei. These findings indicate that p53 is important to
prevent multinucleation in response hepatic injury. Combined deletion of Rb and p53
enhances this polyploid phenotype presumably through more DNA damage, because both
tumor suppressors are important guardians of the genome. Moreover, metabolism of DDC by
Cyp enzymes is associated with the generation of reactive oxygen species (ROS) and oxidative
stress on hepatocytes [23], which is in line with our finding that DDC exposure enhances liver
cell polyploidy. Noteworthy, protoporphyrin can act in a dark environment such as the liver as
antioxidant by scavenging peroxyl radicals [23]. Since RbΔ/Δ;p53Δ/Δ livers show less protopor-
phyrin accumulation and consequently less antioxidants, the increase in hepatocellular injury
and polyploidy might also be related to more oxidative stress (Fig 4).
Oxidative stress is known to mediate damage to cell structures including lipids, proteins and
DNA [35]. The Rb and p53 tumor suppressor pathways are activated in response to DNA dam-
age in order to block proliferation, induce apoptosis or enhance DNA repair [9–12]. Because
DDC causes oxidative stress and presumably DNA damage, the tumor suppressor functions of
Rb and p53 are most likely activated to protect the genome of hepatocytes. p53 activation most
likely leads to activation of p21Cip/Waf cyclin-dependent kinase inhibitor, resulting in a cell
cycle arrest and possibly senescence [36]. Moreover, DNA damage has been shown to activate
p16, another cyclin-dependent kinase inhibitor, which prevents Rb phosphorylation and
inhibit E2F mediated transactivation [11]. However, inactivation of Rb or p53 alone had no
major effect on hepatocellular proliferation or apoptosis in response to DDC, suggesting that
Rb and p53 could partially compensate for each other functions. It has been shown that the
p53 pathway could mediate compensatory cell cycle exit and apoptosis in the absence of Rb
[37]. Lacking of both Rb and p53, DDC-induced injured hepatocytes continued to proliferate.
Unrestricted hepatocyte proliferation under oxidative stress condition could result in genomic
instability, which is supported by the increase in cell death and polyploidy after DDC exposure.
Long-term follow up studies revealed that these mice developed HCC even so DDC expo-
sure was stopped after 3 weeks, indicating that loss of Rb and p53 in presence of DDC resulted
in the formation of preneoplastic lesions that ultimately progressed to liver tumors. DDC expo-
sure to wild-type mice did not result in spontaneous liver tumors. Individual deletion of Rb or
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p53 resulted in the formation of liver tumors as well, but with longer latency, lower frequency
and less malignancy compared to combined deletion of Rb and p53. This less aggressive tumor
phenotype of individual knockout mice corresponded with less cell death, less proliferation
and less polyploidy of hepatocytes during DDC exposure. These studies are in line with studies
showing that Rb and p53 suppress tumorigenesis in response to carcinogens [4,38,39]. How-
ever, here we demonstrate that a non-carcinogenic drug, such as DDC, can enhance tumori-
genesis in livers deficient for Rb and p53.
In summary, we demonstrate that Rb and p53 are not only important for tumor suppres-
sion, but are also critical for xenobiotic metabolism in the liver. Based on the fact that Rb and
p53 are frequently inactivated in liver cancers through hepatitis B or C virus infection, reduced
xenobiotic metabolism in these livers could influence the efficacy or toxicity of therapeutic
drugs or toxins respectively. Since Rb and p53 influence the expression of a large set of Cyp
enzymes, evaluation of the status of Rb and p53 in the liver before treatment of human patients,
might be important in order to adjust the therapeutic window of drugs.
Supporting Information
S1 Fig. Confirmation for genetic deletion of Rb and p53 genes in liver tissue and tumors.
Genotyping PCR for Cre, Rb and p53 on normal livers (L) and liver tumors (T) from Alb-cre
mice carrying conditional floxed alleles for Rbf/f and p53 f/f alleles. Δ stands for deleted allele.
(TIF)
S2 Fig. Mice fed with DDC have yellowish mucous membrane, darker livers and increase
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cut livers of mice after 3 weeks of DDC diet or control (normal chow). (B) Percentage of liver
weight to body weight of mice after 3 weeks of DDC diet or control (normal chow).
(TIF)
S3 Fig. Macrophages and hepatic stellate cells were reduced upon loss of Rb and p53. (A)
Quantitative analysis of macrophages number per high power field (HPF) and representative
pictures of F4/80 staining in mice of indicated genotypes after 3 weeks of DDC. (B) Quantita-
tive analysis of hepatic stellate cells number per high power field (HPF) and representative pic-
tures of GFAP staining in mice of indicated genotypes after 3 weeks of DDC.
(TIF)
S4 Fig. Proliferation rates of bile duct cells and oval cells did not differ between the four
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